• Fumitake Ono, Shinichiro Yasumoto, Minao Furumura, Takahiro Hamada, Norito Ishii, Takashi Gyotoku, Mitsunari Higuchi, Kenichiro Inokuchi, Kazuo Jyo, Hideaki Koga, Ayako Komai, Koji Maruta, Tami Mashiko, Tsukasa Mihara, Hiroko Miyahara, Minoru Miyasato, Koichiro Muto, Koichi Nagase, Masakazu Nagata, Hideki Sakihama, Tomoko Tanahashi, Atsuto Ueda, Kyoko Yamakawa, Chika Ohata, Teruki Dainichi, Daisuke Tsuruta, and Takashi Hashimoto.
• Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Japan.
• J. Dermatol. 2012 Nov 1; 39 (11): 902-8.

AbstractFamciclovir is a guanine analog antiviral drug used commonly for herpes zoster. Efficacy of famciclovir treatment has been reported to be comparable to valacyclovir treatment. Both of these medications reduce the time to complete cessation of zoster-associated pain including post-herpetic neuralgia, as compared to acyclovir. We conducted a multicenter, randomized, open clinical trial in order to evaluate the extent of pain relief afforded by these two antiviral drugs during the acute disease phase of herpes zoster. The study group comprised 86 immunocompetent adult patients suffering from herpes zoster, who were treated with either famciclovir or valacyclovir for 7 days. Of these, 55 patients enrolled in this study within 72 h of the onset of the rash and 31 patients after 72 h of the onset. There was a significant reduction in acute herpes zoster pain with famciclovir on day 7 and at 2-3 weeks in both of these patient groups, while with valacyclovir, there was not significant reduction in pain on day 7. Of patients aged 50 years or older, there was a significantly earlier reduction in pain with famciclovir than with valacyclovir. In addition, a significant reduction in the number of patients with pain was observed as early as days 3-4 with famciclovir treatment as compared with valacyclovir treatment. We conclude that famciclovir was superior to valacyclovir in the relief of acute pain of herpes zoster. Accordingly, famciclovir is recommended for herpes zoster patients with moderate symptoms and a visual analog scale score of under 50 mm.© 2012 Japanese Dermatological Association.

30 keywords...

hide…